Respiratory Inhalers Market Size to Reach Revenues of around $5 Billion by 2025 - Arizton

CHICAGO, Aug. 27, 2020 /PRNewswire/ -- The global respiratory inhalers market is expected to grow at a CAGR of over 9% during the period 2019-2025.

https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg

Key Highlights Offered in the Report:

    1. The US accounted for the major share of global inhalers market; it is
       likely to witness incremental growth rate of around $592 million during
       the forecast.

    2. The MDI accounted for the major share in 2019, however the DPI in this
       segment accounted for the second largest share with the highest absolute
       growth of around 73% of growth during the forecast period.

    3. Based on the distribution channel, the hospitals and pharmacies accounted
       for the major share and are expected to dominate during the forecast
       period. This segment is expected to post an incremental growth of around
       $890 million during the forecast period.

    4. The adults segment accounted for the larger share of the market in 2019.
       This is expected to witness an absolute growth of more than 78% during
       the forecast period.

    5. The impact of COVID-19 on the market has created the sudden surge in
       demand for inhalers, this is due to the usage of the inhalers for
       COVID-19 treatments, which is creating shortage for the inhalers for the
       asthma patients across the globe. The market is expected to function
       normally from the last quarter of 2021 or by the early 2022.
    6. Vendors are actively engaged in the development of the new product and
       commercially launched patient friendly products with enhanced drug
       transfer featuring the latest DPI and SMI in recent years.

Key Offerings:

    --  Market Size & Forecast by Revenue | 2019-2025
    --  Market Dynamics - Leading trends, growth drivers, restraints, and
        investment opportunities
    --  Market Segmentation - A detailed analysis by products, patient,
        distribution channel, and geography
    --  Competitive Landscape - 5 key vendors and 14 other vendors

Get your sample today! https://www.arizton.com/market-reports/respiratory-inhalers-market-size-analysis

Respiratory Inhalers Market - Segmentation

    --  In 2019, the DPI segment accounted for the share of 46% of the global
        respiratory inhalers market. The increased efficiency of drug usage is
        the major driving force for the growth of DPIs. Drug deposition in the
        lung was twice than of pMDI, which suggests a low dosage of the drug
        with reduced side-effects helps to achieve the same degree of asthma
        control.
    --  The adult population is widely exposed to several environmental risk
        factors such as air and workplace pollutions and the consumption of
        tobacco. This contributes to the high share of the adult population in
        the market. While the prevalence of asthma is increasing in several
        countries, multiple factors are affecting the incidence of asthma in the
        adult population.
    --  Hospitals are the first point of contact for the evaluation and
        treatment of respiratory diseases such as asthma and COPD. As the number
        of hospitals has grown over the period, the count of hospital pharmacies
        has also increased. In the middle- and low-income countries, several
        smaller clinics, nursing homes have tie-ups with hospital pharmacies to
        refer patients to purchase branded medical devices for the usage.

Respiratory Inhalers Market by Product

    --  Metered Dosage Inhaler
    --  Dry Powder Inhaler

Respiratory Inhalers Market by Patient

    --  Adults
    --  Pediatric

Respiratory Inhalers Market by Distribution Channel

    --  Hospital Pharmacies
    --  Retail
    --  Online

Respiratory Inhalers Market - Dynamics

The demand for smart inhalers is higher in APAC and Europe due to the rise in the prevalence of asthma, COPD, and other respiratory problems. With the rising adoption of digital technology, the demand for smart inhalers is expected to rise at a significant rate. Various vendors are also focusing on the introduction of smart inhalers in the market. Various global players are partnering with contract manufacturers to procure smart inhalers technology. For instance, GlaxoSmithKline, Boehringer Ingelheim and Novartis have signed development deals with Propeller Health. Similarly, AstraZeneca has signed a master supply agreement with Adherium. Novartis is also working with US mobile technology company Qualcomm for smart inhalers.

Key Drivers and Trends fueling Market Growth:

    --  Introduction of Soft Mist Inhalers
    --  Surge in Inhalers Usage due to COVID-19
    --  Respiratory Inhalers Designed to the Specific Drugs
    --  Technological Advances in Inhalers

Respiratory Inhalers Market - Geography

In North America, both the US and Canada experienced large-scale adoption of inhalers over the past decade. The rise in pollution rate, along with the growing number of cases related to respiratory troubles, even for neo-natal care, is one of the major reasons that boosted the overall demand for inhalers in North America. In addition, more than 50 lakh people are affected by novel coronavirus and are admitted to emergency rooms and are on ventilators. This high demand for ventilators is also supported by inhalers for increased effectiveness of the medicine.

Get your sample today! https://www.arizton.com/market-reports/respiratory-inhalers-market-size-analysis

Respiratory Inhalers Market by Geography

    --  North America
        --  US
        --  Canada
    --  Europe
        --  UK
        --  Germany
        --  France
        --  Italy
        --  Spain
    --  APAC
        --  China
        --  Japan
        --  South Korea
        --  Australia
        --  India
    --  Latin America
        --  Brazil
        --  Mexico
        --  Argentina
    --  Middle East & Africa
        --  South Africa
        --  Saudi Arabia
        --  Turkey

Prominent Vendors

    --  GlaxoSmithKline
    --  Novartis
    --  Boehringer Ingelheim
    --  Cipla
    --  AstraZeneca

Other Prominent Vendors

    --  Propeller Health
    --  Beximco Pharmaceuticals (Beximco Pharma)
    --  H&T Presspart
    --  Cohero Health
    --  CHIESI Farmaceutici
    --  Mundipharma
    --  3M
    --  HELTMAN Medikal
    --  Adherium
    --  Luckys Pharma
    --  Amiko Digital Health
    --  Teva Pharmaceutical Industries
    --  Findair Sp.z.o.o
    --  Vectura Group

Explore our healthcare & lifesciences profile to know more about the industry.

Read some of the top-selling reports:

    --  Nebulizer Market - Global Outlook and Forecast 2020-2025
    --  Medical Ventilator Market - Global Outlook and Forecast 2020-2025
    --  Pulse Oximeters Market - Global Outlook and Forecast 2020-2025
    --  Hospital Beds Market - Global Outlook and Forecast 2020-2025

About Arizton:

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Mail: enquiry@arizton.com

Call: +1-312-235-2040
+1-302-469-0707

View original content:http://www.prnewswire.com/news-releases/respiratory-inhalers-market-size-to-reach-revenues-of-around-5-billion-by-2025--arizton-301119662.html

SOURCE Arizton Advisory & Intelligence